Delivery Order SPE2DR25D2101-SPE2DR26F47FT
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,048.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. The order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $11,571.48 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The order was competitively awarded without set-aside restrictions and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,894.92 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count). This firm fixed-price contract, effective January 12, 2026, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $10,273.02 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The award was made on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction and is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $68,762.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract. The award, announced on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $30,717.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity 90) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $36,477.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $121,701.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 12, 2026, with completion scheduled for January 13, 2026. This firm fixed-price, competitively awarded contract—which includes no set-aside designation—will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47FTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,149.10 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was issued on January 12, 2026, with an ultimate completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities globally to support military healthcare operations. The Jardiance order represents a routine fulfillment of diabetes medication requirements within the Defense Health Agency's pharmaceutical supply chain, consistent with the company's extensive portfolio of brand-name and generic pharmaceutical products supplied through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 1/11/26 |